Augusta Oncology Associates PC

Information may not be reliable

Welcome

Augusta Oncology Associates is committed to providing advanced, high quality, hematology and oncology services to patients and their families by offering access to clinical research, support programs and an educated, caring staff. Augusta Oncology Associates consists of 7 physicians working together on a rotating basis in the hospital, office and “on call” in order to provide continuous, around the clock coverage for those patients who are referred to our practice.

Emergencies and Phone Calls
Insurance & Billing

Patient Bill of Rights

Miriam Yvette Jones Atkins, MD
Richard H. Bromer, MD

Introduction to Cancer Treatment

Questions to Ask
A Word about Clinical Trials
Getting a Second Opinion

General Cancer Information

Stem Cell Transplantation
Side Effects of Cancer Treatment
Complementary and Alternative

Diagnostics & Monitoring Tests

Complementary Alternative Medicine

Lung Cancer - Non-Small Cell
Lung Cancer - Small Cell

What Are Clinical Trials?
Phases of Clinical Trials
How are Clinical Trials Conducted?
Clinical Trial Safeguards
Participating in Clinical Trials
The Cost of Clinical Trials
Finding Specific Clinical Trials
The Future of Clinical Trials

Support & Resources

Hints for Patients and Friends

Birth Control and Sexuality
Home Health Care
Financial and Insurance Issues

Latest Cancer News

Breast Cancer Patients More Satisfied with Silicone Implants (11-12-2010)
Women diagnosed with breast cancer who have undergone mastectomy and breast reconstruction report somewhat higher satisfaction with silicone implants than with saline implants. These findings were published... Continue Reading
Stool DNA Test Shows Promise as Colorectal Cancer Screening Tool (11-11-2010)
An investigational stool DNA test may be effective as a screening tool for colorectal cancer. These findings were recently presented at the American Association for Cancer Research special conference on... Continue Reading
Reduced Chemotherapy Regimen May Be Effective in Neuroblastoma (11-10-2010)
According to results of a Phase III clinical trial, patients with intermediate-risk neuroblastoma may be effectively treated with reduced doses of chemotherapy given over a shorter period. These findings... Continue Reading